Submitted:
30 June 2026
Posted:
01 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Patient Selection
2.2. Clinical Assessment
2.3. Surgical Technique
2.4. Functional Outcome Assessment
2.5. Complications, Recurrence and Reoperation
2.6. Statistical Analysis
3. Results
4. Discussion
4.1. Limitations
5. Conclusions
Author Contributions
Funding
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| GMFCS: Gross Motor Function Classification System FMS: Functional Mobility Scale PMR: Posteromedial release AFO: Ankle-foot orthosis IQR: Interquartile range MMfC: Myelomeningocele Functional Classification Institutional Review Board Statement: Institutional Review Board. |
References
- Swaroop, V.T.; Dias, L. Orthopaedic management of spina bifida—Part II: Foot and ankle deformities. J. Child. Orthop. 2011, 5, 403–414. [CrossRef]
- Matar, H.E.; Beirne, P.; Garg, N.K. Effectiveness of the Ponseti method for treating clubfoot associated with myelomeningocele: 3–9 years follow-up. J. Pediatr. Orthop. B 2017, 26, 133–136. [CrossRef]
- Ferreira dos Santos, T.; Ferraz Ferreira, G.; Nogueira, M.P. Effectiveness of congenital myelodysplastic clubfoot treatment by the Ponseti method—Systematic review. PLoS ONE 2024, 19, e0304909. [CrossRef]
- Alsiddiky, A.; Alghnimei, N.; Alfadhil, R.; Alharbi, S.K.; Alsharidah, A.M.; Albusayes, N.; Albarrak, R.; Alsubaie, A.A. Targeted minimally invasive percutaneous posteromedial release of residual clubfoot in myelomeningocele patients: A report of two cases. Cureus 2022, 14, e27084. [CrossRef]
- Arkin, C.; Ihnow, S.; Dias, L.; Swaroop, V.T. Midterm results of the Ponseti method for treatment of clubfoot in patients with spina bifida. J. Pediatr. Orthop. 2018, 38, e588–e592. [CrossRef]
- Janicki, J.A.; Narayanan, U.G.; Harvey, B.; Roy, A.; Ramseier, L.E.; Wright, J.G. Treatment of neuromuscular and syndrome-associated (nonidiopathic) clubfeet using the Ponseti method. J. Pediatr. Orthop. 2009, 29, 393–397. [CrossRef]
- Gerlach, D.J.; Gurnett, C.A.; Limpaphayom, N.; Alaee, F.; Zhang, Z.; Porter, K.; Kirchhofer, M.; Smyth, M.D.; Dobbs, M.B. Early results of the Ponseti method for the treatment of clubfoot associated with myelomeningocele. J. Bone Joint Surg. Am. 2009, 91, 1350–1359. [CrossRef]
- Flynn, J.M.; Herrera-Soto, J.A.; Ramirez, N.F.; Fernandez-Feliberti, R.; Vilella, F.; Guzman, J. Clubfoot release in myelodysplasia. J. Pediatr. Orthop. B 2004, 13, 259–262. [CrossRef]
- May, J.M.; DeMaio, E.L.; Larson, J.E. Long-term clinical and radiographic results of posteromedial lateral release for neuromuscular clubfoot deformity. J. Pediatr. Orthop. 2025, 45, 87–92. [CrossRef]
- Watanabe, H.; Fukushima, T.; Taki, N.; Sugawara, R.; Inoue, H.; Takeshita, K.; Yamazaki, M. Posteromedial release combined with arthrodesis of the talocalcaneal and calcaneocuboid joints for equinovarus associated with myelodysplasia: Clinical outcomes assessment preliminary report. J. Orthop. Sci. 2019, 24, 320–325. [CrossRef]
- Graham, H.K.; Harvey, A.; Rodda, J.; Nattrass, G.R.; Pirpiris, M. The Functional Mobility Scale. J. Pediatr. Orthop. 2004, 24, 514–520. [CrossRef]
- Palisano, R.; Rosenbaum, P.; Walter, S.; Russell, D.; Wood, E.; Galuppi, B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev. Med. Child Neurol. 1997, 39, 214–223. [CrossRef]
- Dias, L.S.; Swaroop, V.T.; de Angeli, L.R.A.; Larson, J.E.; Rojas, A.M.; Karakostas, T. Myelomeningocele: A new functional classification. J. Child. Orthop. 2021, 15, 1–5. [CrossRef]
- Sharrard WJ. The segmental innervation of the lower limb muscles in man. Ann R Coll Surg Engl. 1964 Aug;35(2):106-PMID: 14180405; PMCID: PMC2311748.
- Diméglio, A.; Bensahel, H.; Souchet, P.; Mazeau, P.; Bonnet, F. Classification of clubfoot. J. Pediatr. Orthop. B 1995, 4, 129–136. [CrossRef]
- Davoli, G.B.Q.; Chaves, T.C.; Lopes, M.S.; Martinez, E.Z.; Sobreira, C.F.R.; Graham, H.K.; Ferreira, C.H.J. The cross-cultural adaptation, construct validity, and intra-rater reliability of the Functional Mobility Scale in Brazilian Portuguese for children and adolescents with spina bifida. Disabil. Rehabil. 2022, 44, 4862–4870. [CrossRef]
- Kumar, R.; Mehrotra, A.; Banerjee, S. Neuro-orthopaedic conditions in spina bifida: Natural course and their management and long-term outcomes. Childs Nerv. Syst. 2013, 29, 1581–1587. [CrossRef]
- McDonald, C.M.; Jaffe, K.M.; Mosca, V.S.; Shurtleff, D.B. Ambulatory outcome of children with myelomeningocele: Effect of lower-extremity muscle strength. Dev. Med. Child Neurol. 1991, 33, 482–490. [CrossRef]
- Samineni, A.V.; Miller, P.E.; Hopkinson, C.; DiFazio, R.; Quigley, S.; Watkins, C.J.; Shore, B.J. Determining incidence and risk factors of pressure injury after orthopaedic surgery in children and adolescents with neuromuscular complex chronic conditions. J. Pediatr. Orthop. 2022, 42, 564–570. [CrossRef]


| Variable | Overall (n=39) |
| Age at surgery, years, mean ± SD (range) | 4.2 ± 2.4 (2–12.6) |
| Sex, n (%) | |
| Male | 22 (56.4) |
| Female | 17 (43.6) |
| Laterality, n (%) | |
| Unilateral | 23 (59.0) |
| Bilateral | 16 (41.0) |
| Sharrard neurological level | |
| Thoracic, n (%) | 4 (10.3) |
| High lumbar, n (%) | 14 (35.9) |
| Low lumbar, n (%) | 16 (41.0) |
| Sacral, n (%) | 5 (12.8) |
| Preoperative functional status | |
| Preoperative GMFCS, median (IQR) | III (II–IV) |
| Preoperative FMS 5 m, median (IQR) | 3 [2–5] |
| Preoperative FMS 50 m, median (IQR) | 3 [2–4] |
| Preoperative FMS 500 m, median (IQR) | 1 [1–2] |
| Preoperative FMS total [3–18], median (IQR) | 7 [5–10] |
| Follow-up duration, years, mean (range) | 3.7 (2.0–10.1) |
| Variable | Overall (n=55) |
| Foot-level baseline characteristics | |
| Side, right, n (%) | 29 (52.7) |
| Side, left, n (%) | 26 (47.3) |
| Quadriceps function, absent (–), n (%) | 20 (36.4) |
| Quadriceps function, present (+), n (%) | 35 (63.6) |
| Dimeglio severity | |
| Moderate, n (%) | 13 (23.6) |
| Severe, n (%) | 30 (54.5) |
| Very severe, n (%) | 12 (21.8) |
| Index surgical procedures, n (%)* | |
| Posteromedial release | 55 [100] |
| Plantar fasciotomy, n (%) | 26 (47.2) |
| Cuboid osteotomy, n (%) | 8 (14.5) |
| Tibialis anterior tendon transfer, n (%) | 5 (9.1) |
| Outcome | Time | Moderate (n=10) | Severe (n=20) | Very severe (n=9) | p(between groups) † |
| GMFCS | Preop | III (II–III) | III (III–IV) | IV (III–IV) | < 0.001 |
| Postop | III (II–III) | III (II–IV) | IV (III–IV) | 0.004 | |
| p (pre vs post)* | 0.317 | 0.083 | 0.248 | ||
| FMS 5 m | Preop | 4 [3–5] | 3 [2–4] | 2 [1–3] | < 0.001 |
| Postop | 4 [3–6] | 4 [3–5] | 3 [2–4] | 0.006 | |
| p (pre vs post)* | 0.157 | 0.012 | 0.031 | ||
| FMS 50 m | Preop | 4 [3–5] | 3 [2–4] | 1 [1–2] | < 0.001 |
| Postop | 5 [4–6] | 4 [3–5] | 3 [2–4] | 0.002 | |
| p (pre vs post)* | 0.008 | < 0.001 | 0.002 | ||
| FMS 500 m | Preop | 2 [1–3] | 1 [1–2] | 1 [1–1] | < 0.001 |
| Postop | 3 [2–4] | 2 [1–3] | 1 [1–2] | 0.041 | |
| p (pre vs post)* | 0.012 | <0.001 | 0.109 | ||
| FMS total [3–18] | Preop | 10 [8–12] | 7 [5–9] | 4 [3–6] | < 0.001 |
| Postop | 13 [11–15] | 10 [8–12] | 7 [5–9] | 0.009 | |
| p (pre vs post)* | 0.004 | < 0.001 | 0.018 |
| Outcome | Time | Thoracic (n=4) | High lumbar (n=14) | Low lumbar (n=16) | Sacral (n=5) | p† |
| GMFCS | Preop | IV (IV–V) | IV (III–IV) | III (II–III) | II (I–II) | < 0.001 |
| Postop | IV (IV–V) | IV (II–IV) | II (II–III) | II (I–II) | < 0.001 | |
| p * | 1.000 | 0.157 | 0.030 | 0.317 | ||
| FMS 5 m | Preop | 1 (1–2) | 1 (1–2) | 4 (3–5) | 5 (4–6) | <0.001 |
| Postop | 2 (1–3) | 2 (2–4) | 5 (4-6) | 6 (5–6) | <0.001 | |
| p | 0.157 | 0.074 | 0.008 | 0.157 | - | |
| FMS 50 m | Preop | 1 (1–1) | 2 (1–4) | 4 (3.25–5) | 6 (6–6) | <0.001 |
| Postop | 1 (1–1) | 2 (2–3) | 5 (3.25–5) | 6 (6–6) | <0.001 | |
| p * | 1.000 | 0.003 | 0.003 | 0.034 | — | |
| FMS 500 m | Preop | 1 (1–1) | 1 (1–1) | 1 (1–1) | 4 (2–4.5) | <0.001 |
| Postop | 1 (1–1) | 1 (1–1) | 3 (1.5–3.75) | 6 (5–6) | <0.001 | |
| p * | 1.000 | 0.157 | 0.002 | 0.041 | — | |
| FMS total (3–18) | Preop | 3 (3–3) | 5 (3–5) | 8.5 (5.5–9.75) | 14 (11.5–15) | <0.001 |
| Postop | 3 (3–3) | 5 (5–8) | 13 (10.25–14) | 18 (17–18) | <0.001 | |
| p * | 1.000 | 0.002 | 0.001 | 0.042 | — |
| Outcome | Time |
Quadriceps absent (n=18) |
Quadriceps present (n=21) |
p value† |
| GMFCS | Preop | IV (III–IV) | III (II–III) | 0.001 |
| Postop | IV (III–IV) | III (II–III) | 0.001 | |
| FMS 5 m | Preop | 2 (1-3) | 4 (3-5) | <0.001 |
| Postop | 3 (2-4) | 5 (4-5) | <0.001 | |
| FMS 50 m | Preop | 2 (1-3) | 4 (3-5) | <0.001 |
| Postop | 2 (2-4) | 5 (4-5) | <0.001 | |
| FMS 500 m | Preop | 1 (1-1) | 2 (1-3) | 0.004 |
| Postop | 1 (1-2) | 3 (2-4) | 0.002 | |
| FMS total (3-18) | Preop | 5 (3-7) | 8 (7-13) | 0.002 |
| Postop | 6 (5-10) | 12 (10-14) | <0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).